VARANI, Katia
 Distribuzione geografica
Continente #
NA - Nord America 30.693
EU - Europa 9.240
AS - Asia 7.231
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 16
AF - Africa 6
Totale 47.229
Nazione #
US - Stati Uniti d'America 30.612
CN - Cina 3.565
UA - Ucraina 2.275
DE - Germania 2.028
TR - Turchia 1.755
IT - Italia 1.663
SG - Singapore 1.511
GB - Regno Unito 982
SE - Svezia 742
FI - Finlandia 569
PL - Polonia 316
RU - Federazione Russa 213
FR - Francia 137
ID - Indonesia 114
HK - Hong Kong 109
BE - Belgio 98
VN - Vietnam 83
CA - Canada 77
CZ - Repubblica Ceca 59
NL - Olanda 52
LT - Lituania 25
IN - India 21
ES - Italia 20
IR - Iran 20
EU - Europa 18
JP - Giappone 15
AU - Australia 11
AT - Austria 10
RO - Romania 10
BR - Brasile 9
CL - Cile 8
CH - Svizzera 6
KR - Corea 6
HU - Ungheria 5
IE - Irlanda 5
IL - Israele 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
GR - Grecia 4
MX - Messico 4
MY - Malesia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
HR - Croazia 3
MA - Marocco 3
NO - Norvegia 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
DZ - Algeria 2
IM - Isola di Man 2
IQ - Iraq 2
JO - Giordania 2
MD - Moldavia 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
KH - Cambogia 1
LB - Libano 1
MC - Monaco 1
ME - Montenegro 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 47.229
Città #
Woodbridge 3.958
Fairfield 3.394
Jacksonville 2.602
Chandler 2.498
Houston 2.382
Ann Arbor 2.135
Ashburn 1.766
Wilmington 1.418
Seattle 1.328
Singapore 1.160
Cambridge 1.109
Santa Clara 1.095
Izmir 893
Nanjing 783
Beijing 662
Princeton 585
Boardman 470
Ferrara 453
Milan 312
Warsaw 312
San Diego 302
Shanghai 302
Nanchang 250
Shenyang 232
Los Angeles 209
Dearborn 179
Bremen 167
Changsha 148
Hebei 148
New York 146
Tianjin 143
Addison 140
Jiaxing 136
Jakarta 113
Hong Kong 106
San Mateo 99
Brussels 97
Falls Church 90
Jinan 87
London 86
Norwalk 83
Zhengzhou 82
Dong Ket 81
Kunming 77
Munich 72
Helsinki 70
Mountain View 70
Auburn Hills 59
Orange 58
Düsseldorf 54
Ningbo 53
Guangzhou 49
Redwood City 49
Philadelphia 47
Washington 43
Des Moines 39
Brno 37
Tappahannock 37
Toronto 37
Bologna 35
Frankfurt am Main 34
Taizhou 34
Augusta 32
Indiana 30
Rome 29
Verona 29
Chicago 28
Hangzhou 28
Lanzhou 25
Redmond 21
Haikou 17
Hefei 17
Leawood 17
Olomouc 17
Ottawa 17
Ardabil 16
Ferrara di Monte Baldo 16
Florence 16
Kilburn 16
San Francisco 13
Changchun 12
Espoo 12
Bari 11
Chiswick 11
Padova 11
Aversa 9
Meppel 9
Otura 9
Taiyuan 9
Amsterdam 8
Hounslow 8
Monmouth Junction 8
Naples 8
Cagliari 7
Edinburgh 7
Fuzhou 7
Mcallen 7
New Bedfont 7
Tokyo 7
Catania 6
Totale 34.252
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 337
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 236
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 201
A glance at adenosine receptors: Novel target for antitumor therapy 200
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 197
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 196
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 186
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 167
The A3 adenosine receptor: history and perspectives 166
Pharmacology of Adenosine Receptors: The State of the Art 164
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 163
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 160
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 160
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 158
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 157
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 156
Recettori e trasduzione del segnale 155
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 151
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 149
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 149
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 146
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 146
Adenosine receptors and human melanoma 145
Pathological overproduction: the bad side of adenosine 145
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 144
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 144
Adenosine receptor targeting in health and disease 142
Current status of A1 adenosine receptor allosteric enhancers 142
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 142
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 140
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 140
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 137
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 136
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 135
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 135
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 135
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 134
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 132
Recettori e trasduzione del segnale 131
Comparison of Prazosin, Terazosin and Tamsulosin: Functional and Binding Studies in Isolated Prostatic and Vascular Human Tissues. 131
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 131
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 131
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 130
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 130
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 129
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 129
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 129
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 128
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 128
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 127
Ala scan analogues of HOE 140. Synthesis and biological activities 127
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 127
A Consensus Panel Review of Central Nervous System Effects of the Exposure to Low-Intensity Extremely Low-Frequency Magnetic Fields 127
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 127
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 127
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 127
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 127
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 126
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 125
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 124
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 124
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 124
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 124
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 124
Adenosine signaling contributes to ethanol-induced fatty liver in mice 123
Binding thermodynamics at A1 and A2A adenosine receptors 123
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 123
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 123
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 123
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 122
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 122
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 122
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 122
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 122
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 122
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 121
null 121
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 120
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 120
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 120
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 119
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 119
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 119
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 119
Biochemical characterization of A1 adenosine receptors: experimental evaluation of their binding and intrinsic activity parameters 118
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 118
New potent and selective human adenosine A3 receptor antagonists. 118
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 117
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 117
Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligands 116
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 116
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 116
Conformational Aspects of Human Formyl-peptide Receptor Agonists 116
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 116
Adenosine and lymphocyte regulation 116
Agonists and antagonists: Molecular mechanisms and therapeutic applications 116
Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats 115
The A3 adenosine receptor: an enigmatic player in cell biology. 115
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 115
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 115
Totale 13.727
Categoria #
all - tutte 211.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.671
Totale 216.597


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.459 0 0 0 0 502 1.027 757 906 636 1.021 463 147
2020/20216.868 600 670 242 788 344 711 276 826 165 951 888 407
2021/20225.145 126 552 340 225 245 210 232 269 193 432 731 1.590
2022/20235.734 592 432 176 795 954 821 269 458 700 46 296 195
2023/20242.851 289 377 142 83 316 343 136 209 57 72 77 750
2024/20253.528 311 354 946 618 1.299 0 0 0 0 0 0 0
Totale 47.901